Marshall Wace LLP Boosts Holdings in ASP Isotopes Inc. (NASDAQ:ASPI)

Marshall Wace LLP lifted its position in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 389.6% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 545,072 shares of the company’s stock after buying an additional 433,734 shares during the period. Marshall Wace LLP owned approximately 1.05% of ASP Isotopes worth $1,668,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors have also recently made changes to their positions in the company. Fielder Capital Group LLC acquired a new stake in ASP Isotopes during the second quarter worth $55,000. Rhumbline Advisers purchased a new position in shares of ASP Isotopes during the 2nd quarter worth $116,000. Virtu Financial LLC increased its position in shares of ASP Isotopes by 477.0% during the 1st quarter. Virtu Financial LLC now owns 83,677 shares of the company’s stock worth $346,000 after purchasing an additional 69,176 shares during the last quarter. HTLF Bank raised its holdings in ASP Isotopes by 197.0% in the 2nd quarter. HTLF Bank now owns 105,538 shares of the company’s stock valued at $323,000 after buying an additional 70,000 shares during the period. Finally, Bank of New York Mellon Corp acquired a new position in ASP Isotopes in the second quarter valued at about $381,000. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Trading Up 3.0 %

NASDAQ ASPI opened at $3.10 on Friday. The company has a debt-to-equity ratio of 2.06, a quick ratio of 4.00 and a current ratio of 4.00. The firm has a market cap of $160.47 million, a price-to-earnings ratio of -5.85 and a beta of 5.11. The firm has a 50 day simple moving average of $2.48 and a 200-day simple moving average of $3.32. ASP Isotopes Inc. has a one year low of $0.84 and a one year high of $5.67.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings results on Monday, August 19th. The company reported ($0.24) EPS for the quarter. The business had revenue of $1.02 million for the quarter. Equities research analysts anticipate that ASP Isotopes Inc. will post -0.24 EPS for the current fiscal year.

Insider Activity at ASP Isotopes

In related news, major shareholder Ak Jensen Investment Managemen purchased 61,849 shares of the business’s stock in a transaction on Wednesday, July 10th. The shares were bought at an average price of $3.40 per share, for a total transaction of $210,286.60. Following the acquisition, the insider now directly owns 6,678,723 shares in the company, valued at $22,707,658.20. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 26.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on ASPI shares. Canaccord Genuity Group started coverage on shares of ASP Isotopes in a research note on Friday. They issued a “buy” rating and a $4.50 price target on the stock. HC Wainwright cut their target price on ASP Isotopes from $5.50 to $4.50 and set a “buy” rating on the stock in a research report on Wednesday, August 7th. Finally, Canaccord Genuity Group assumed coverage on ASP Isotopes in a research report on Friday. They set a “buy” rating and a $4.50 price target for the company.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.